| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,768 | 39,572 | 38,294 | 36,177 | | Cost of Revenue | (14,941) | 20,751 | 20,592 | 18,967 | | | Gross Profit | 53,709 | 18,821 | 17,702 | 17,210 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,726 | 7,226 | 6,944 | 6,803 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,497 | 1,499 | 1,425 | 1,184 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,486 | 10,096 | 9,333 | 9,223 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (48) | 11 | (12) | 75 | | Earnings Before Interest And Taxes | 3,024 | 10,107 | 9,321 | 5,088 | | Interest Expense | (4,266) | 2,082 | 2,184 | 1,148 | | Income Before Tax | 7,290 | 8,025 | 7,137 | 3,940 | | Income Tax Expense | 1,191 | 1,356 | 1,106 | 1,537 | | Minority Interest |
-
|
-
|
-
| (4,210) | | | | Net Income From Continuing Ops | 6,099 | 6,669 | 6,031 | 2,403 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,987) | 6,669 | 6,031 | 2,403 | | Preferred Stock And Other Adjustments | 8,849 | (4,547) | (4,302) |
-
| | | Net Income Applicable To Common Shares | $1,862 | $2,122 | $1,729 | $2,403 |
|
0.31% Nasdaq 
0.05%
Income Statement
